APA (7th ed.) Citation

Tsubota, S., Kishida, S., Shimamura, T., Ohira, M., Yamashita, S., Cao, D., . . . Kadomatsu, K. (2017). PRC2-Mediated Transcriptomic Alterations at the Embryonic Stage Govern Tumorigenesis and Clinical Outcome in MYCN-Driven Neuroblastoma. Cancer research (Chicago, Ill.), 77(19), 5259-5271. https://doi.org/10.1158/0008-5472.CAN-16-3144

Chicago Style (17th ed.) Citation

Tsubota, Shoma, Satoshi Kishida, Teppei Shimamura, Miki Ohira, Satoshi Yamashita, Dongliang Cao, Shinichi Kiyonari, Toshikazu Ushijima, and Kenji Kadomatsu. "PRC2-Mediated Transcriptomic Alterations at the Embryonic Stage Govern Tumorigenesis and Clinical Outcome in MYCN-Driven Neuroblastoma." Cancer Research (Chicago, Ill.) 77, no. 19 (2017): 5259-5271. https://doi.org/10.1158/0008-5472.CAN-16-3144.

MLA (9th ed.) Citation

Tsubota, Shoma, et al. "PRC2-Mediated Transcriptomic Alterations at the Embryonic Stage Govern Tumorigenesis and Clinical Outcome in MYCN-Driven Neuroblastoma." Cancer Research (Chicago, Ill.), vol. 77, no. 19, 2017, pp. 5259-5271, https://doi.org/10.1158/0008-5472.CAN-16-3144.